
Note sull'episodio
The selegiline patch (EMSAM) is the MAOI with no diet rules at 6 mg. A PMHNP protocol for candidates, washouts, dosing, tyramine, and monitoring in TRD.
In this Deep Dive episode, two hosts walk through “Selegiline Patch for TRD: A PMHNP Prescribing Protocol” from the Psych NP Fellowship blog by Lindsay Hill, DNP, PMHNP-BC.
Key takeaways:
• The selegiline transdermal system (EMSAM) is an FDA-approved MAOI for adult major depressive disorder, and at 6 mg/24 hours it needs no tyramine diet.
• A 2025 real-world cohort of 117 patients with treatment-resistant depression found the patch was 0.81 CGI-S points better than tricyclics and better tolerated than oral MAOIs, with no hypertensive crises or serotonin syndrome.
• The washout is the dangerous part: about 1 week off most antidepressants, at least 5 weeks off fluoxetine, and 2 weeks after stopping ...
Parole chiave
Psych NP Mentor
Psychopharmacology
PMHNP Mentor
Psych NP Fellowship
Treatment-Resistant Depression
Psych NP Bootcamp
Clinical Practice
antidepressant washout
EMSAM
MAOI
selegiline
